###begin article-title 0
###xml 138 146 <span type="species:ncbi:9606">Patients</span>
Impact of the Pro12Ala Polymorphism of the PPAR-Gamma 2 Gene on Metabolic and Clinical Characteristics in the Palestinian Type 2 Diabetic Patients
###end article-title 0
###begin p 1
Recommended by Mostafa Badr
###end p 1
###begin p 2
###xml 56 61 56 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 401 410 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#947;</italic>
###xml 653 662 645 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#947;</italic>
###xml 855 856 843 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1045 1046 1033 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1109 1110 1097 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1160 1169 1148 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#947;</italic>
###xml 949 957 <span type="species:ncbi:9606">patients</span>
###xml 1266 1274 <span type="species:ncbi:9606">patients</span>
Peroxisome proliferators activated receptor-gamma2 (PPARgamma2) represents the transcriptional master regulator of adipocyte differentiation and therefore has been suggested as a candidate gene for obesity, insulin resistance, and dyslipidemia. The objective of the study was to investigate for the first time the potential association of the most common variant Pro12Ala (p.P12A) substitution of the PPARgamma2 gene with body mass index (BMI), blood pressure, fasting plasma glucose, plasma total cholesterol, LDL and HDL cholesterol, and plasma triglyceride in a sample of 202 (138 females and 64 male) type 2 diabetic Palestinians. Genotyping of the PPARgamma2 p.P12A polymorphism was determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. The A12 allele was associated with lower fasting plasma glucose (P = .03) but had no influence on blood pressure, BMI, or other metabolic parameters. In obese patients, the p.P12A substitution was associated with elevated total plasma cholesterol levels (P = .02) and a tendency toward increased LDL cholesterol level (P = .06). In conclusion, the p.P12A variant of the PPARgamma2 may influence cardiovascular risk through effects on lipid metabolism in obese T2D Palestinian patients.
###end p 2
###begin title 3
1. Introduction
###end title 3
###begin p 4
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
Type 2 diabetes mellitus (T2DM) showed to be a cocktail of genetic discovery as described by Freeman and Cox [1]. T2DM cases would have inborn with a diversity of different genetic factors that together with environmental factors combine as the primary cause and contributed to the disease.
###end p 4
###begin p 5
###xml 129 130 129 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 206 209 <span type="species:ncbi:9606">men</span>
###xml 214 219 <span type="species:ncbi:9606">women</span>
Studies enlightening the epidemiology of diabetes mellitus among Palestinians are scarce. A Palestinian study conducted at 2001 [2] showed DM prevalence in 12% of urban Palestinian population including 492 men and women 30-65 years old. According to the WHO global estimate, and the epidemic nature of diabetes; prevalence of diabetes is expected to increase in Palestine and numbers should be revised to have more realistic estimation, which enables health providers to be aware of the disease magnitude, so that more effective health strategies can be adopted.
###end p 5
###begin p 6
###xml 54 59 54 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 260 265 256 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 375 376 367 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 378 379 370 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 386 392 378 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;2</italic>
###xml 451 452 439 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 525 531 513 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;2</italic>
###xml 684 685 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 737 738 721 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 844 845 828 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 846 848 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 873 875 857 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 876 878 860 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1010 1011 994 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1036 1037 1020 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1216 1217 1200 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1356 1362 1340 1342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;2</italic>
###xml 1023 1031 <span type="species:ncbi:9606">patients</span>
Preoxisome proliferator-activated receptor gamma (PPARgamma) is a nuclear hormone receptor which plays a critical role in regulating adipocyte differentiation and the transcription of genes that are important for lipogenesis. In macrophages, the activated PPARgamma promotes the cellular efflux of phospholipids and cholesterol in the form of high density lipoprotein (HDL) [3, 4]. PPARgamma2 is a key modulator of adipogenesis and insulin signaling [5]. Cytosine to guanine single nucleotide polymorphism (rs1805192) in PPARgamma2 gene (NM_015869) resulting in a proline to alanine substitution at codon 12, which has been found to modulate the transcriptional activity of the gene [6], and associated with altered insulin sensitivity [7]. Although most studies have shown a statistically significant T2DM risk reduction given by Ala variant [8-11], some others have not [12-15], suggesting variability in the contribution of this variant to the risk of T2DM. In a previous study of 333 Palestinian subjects (n = 219 T2DM patients and n = 114 normoglycemic controls), we were unable to demonstrate a significant association between the p.P12A variant and the T2DM among Palestinians (0.055 versus 0.048, OR = 0.87, P = .9) (unpublished data). The aim of this study was to investigate for the first time the relationship between p.P12A polymorphism of PPARgamma2 gene and blood pressure, BMI and other related metabolic parameters in type 2 diabetic Palestinians.
###end p 6
###begin title 7
2. Subjects and Methods
###end title 7
###begin p 8
###xml 183 184 181 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 225 226 223 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 128 135 <span type="species:ncbi:9606">patient</span>
###xml 457 462 <span type="species:ncbi:9606">Human</span>
After an institutional review board approval and a completion of an informed consent, two hundred and two (202) diabetic type 2 patient volunteers (121 obese subjects (BMI >/= 30 kg/m2) and 81 nonobese subjects (BMI < 30 kg/m2) were randomly recruited on the basis of routine visits to the Amari Refugee camp outpatient UNRWA clinic in the Ramallah District, 14 km north Jerusalem. The study protocol and the consent form were approved by the institutional Human Research Ethics Committee at Al-Quds University. The volunteers were unrelated, over 40 years old and diagnosed with diabetes according to WHO criteria or currently being treated with medication for diabetes. Subjects with previous diagnosis of type 1 diabetes were excluded from the study. Complete medical records including family history for diabetes, resting blood pressure, and anthropometric parameters: weight, height, and BMI (weight in kilograms divided by the square of height in meters) were obtained.
###end p 8
###begin p 9
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 441 446 <span type="species:ncbi:9606">Human</span>
For laboratory analysis, 5 mL of blood were obtained after overnight fast. Blood samples were collected in EDTA-tubes and immediately centrifuged at room temperature. Plasma was aliquoted for glucose, cholesterol, HDL-cholesterol, and triglyceride determination. Plasma glucose was determined by a glucose oxidase method. Plasma total cholesterol, triglyceride and HDL cholesterol were determined by enzymatic methods using commercial kits (Human, Wiesbaden, Germany). Plasma LDL cholesterol was calculated by the Friedewald formula [16]. All the biochemical measures were obtained in milligram/deciliter (mg/dL), to convert plasma glucose, triglyceride, and cholesterol values into millimolar concentration (mmol/L). Multiply the given values in (mg/dL) units by 0.0555, 0.0113, and 0.0259, respectively.
###end p 9
###begin p 10
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 341 343 341 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 461 463 460 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
Genomic DNA was extracted from peripheral blood according to standard procedures (Epicenter, Madison, Wis, USA). The p.P12A polymorphism was detected by PCR-RFLP analysis as previously described by Johansen et al. [17] with the following modifications: The PCR reactions were carried out using 100 ng of purified genomic DNA samples, with 1 muM of each primer (forward/reverse) and PCR-Ready Supreme mix (Syntezza Bioscience, Jerusalem) in a final volume of 25 muL.
###end p 10
###begin title 11
3. Statistical Analysis
###end title 11
###begin p 12
###xml 146 147 146 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 466 467 466 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Statistical differences between mean values of the continuous variables of subjects with and without the polymorphism were evaluated by student's t test and confirmed by a nonparametric analysis using Mann-Whitney test. Chi-square analysis was performed to test the allelic frequency differences between obese and nonobese subjects. Hardy-Weinberg equilibrium was computed to the expected genotype distribution. Analysis was performed using SPSS program version 15. P value less than .05 was considered significant.
###end p 12
###begin title 13
4. Results
###end title 13
###begin p 14
###xml 108 115 108 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab1">Table 1</xref>
###xml 861 862 861 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1005 1011 1005 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;2</italic>
###xml 1259 1260 1255 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1372 1379 1368 1375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab2">Table 2</xref>
###xml 1505 1506 1497 1498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1535 1542 1527 1534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab3">Table 3</xref>
###xml 1620 1626 1612 1614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;2</italic>
###xml 493 500 <span type="species:ncbi:9606">patient</span>
###xml 580 587 <span type="species:ncbi:9606">patient</span>
###xml 934 942 <span type="species:ncbi:9606">patients</span>
The biochemical and anthropometric results for the 121 obese subjects and 81 nonobese subjects are shown in Table 1. No significant differences in biochemical parameters were noted between the two groups. The genotype analysis in nonobese subjects revealed that 73 individuals were homozygote for the wild P12P allele, and 8 individuals were heterozygote P12A. Among the obese group, 106 individuals were homozygote for the wild P12P allele, 14 individuals were heterozygote P12A and only one patient was homozygote A12A for the rare allele. Because there was only one homozygote patient for the rare allele, this individual was combined with the heterozygote group and compared with the homozygote wild group in all of the statistical analyses. No significant statistical correlation was observed between medication for diabetes and either genotype or gender (P > .05) in both groups. The overall frequency of the A12 allele in T2DM patients was 0.059 and it was in Hardy-Weinberg equilibrium. Since PPARgamma2 is an important regulator of adipogenesis, it was relevant to verify if the p.P12A variant was associated with obesity. The frequency of the A12 allele did not differ significantly between obese and nonobese diabetic subjects (0.066 versus 0.049, P = 0.6). No significant differences in the genotypic distribution were found between the two groups as shown in Table 2. The presence of A12 variant was significantly associated with lower plasma glucose (174 +/- 45.9 vresus 214 +/- 84.9 mg/dL, P = .03) for the whole group (Table 3). However, there were no significant statistical differences between the PPARgamma2 genotype and gender, age, BMI, plasma triglyceride, plasma total cholesterol, HDL and LDL cholesterol, as well as systolic and diastolic blood pressure.
###end p 14
###begin p 15
###xml 145 146 141 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 255 256 251 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 379 380 375 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 389 396 385 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab3">Table 3</xref>
Among obese subjects, p.P12A carriers showed significantly higher level of plasma total cholesterol (232.2 +/- 41.8 versus 197.1 +/- 52.7 mg/dL, P = .02) and tended with a borderline significant to have lower plasma glucose than those with P12P genotype (P = .05). A tendency toward increased levels of LDL cholesterol among P12A genotype were also observed but not significant (P = .06) (Table 3). Both subgroups showed no association of P12A genotype and triglyceride, and HDL cholesterol.
###end p 15
###begin title 16
5. Discussion
###end title 16
###begin p 17
###xml 58 63 58 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 183 185 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 187 189 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 283 285 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 287 289 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 348 350 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 475 477 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 479 481 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 518 520 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 522 524 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 526 528 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 688 696 <span type="species:ncbi:9606">patients</span>
In this study, the frequency of the A12 allele of the PPARgamma2 gene in diabetic subjects was similar to that reported for other Arabic populations such as Qatari and Tunisian ones [13, 14], but was slightly higher than in East Asian (Malaysians, Chinese, and Koreans) populations [15, 18] and much lower than that reported in Caucasian subjects [19]. This might be explained by the genetic background shared between our studied group and the other Arabic origin subgroups [13, 14] compared with other ethnic groups [15, 18, 19]. More comprehensive genotyping studies are needed to clarify this point. Of at most interest is to recruit and genotype large representative Palestinian T2DM patients to get conclusive results for comparison with the Caucasian group.
###end p 17
###begin p 18
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
In agreement with early published studies, we could not demonstrate an effect of the p.P12A variant on several traits that are associated with insulin resistant syndrome, such the BMI, blood pressure, and plasma triglyceride levels [15, 20].
###end p 18
###begin p 19
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
On the other hand, our study showed the diabetic subjects with the P12A genotype had lower fasting plasma glucose levels than those with the P12P genotype. This effect had a borderline significance in the obese group. Thamer et al. [21] indicated that the mechanism by which the A12 allele improves insulin sensitivity might involve enhanced suppression of lipid oxidation permitting more efficient glucose disposal, however, this effect should be clarified in future studies with detailed laboratory tests such as glycated hemoglobin and insulin sensitivity measures by the gold standard OGTT and/or the hyperinsulinemic euglycemic clamp [22].
###end p 19
###begin p 20
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 397 404 397 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab1">Table 1</xref>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 759 765 759 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;2</italic>
###xml 835 841 831 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;2</italic>
###xml 900 902 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1087 1093 1079 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;2</italic>
###xml 1151 1153 1139 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
Of the variables tested, the P12A genotype had the greatest effect on plasma total cholesterol with an elevated level among diabetic obese than nonobese subjects consistent with early published studies in Caucasian and Japanese populations [8, 19]. Plasma LDL cholesterol exhibited a similar trend, but did not achieve significance. Since both obese and nonobese groups had similar lipid profile (Table 1). This effect is not simply reflected by obesity, it might be revealed due to variable interactions of the Ala allele with other genetic and environmental factors. In the Finnish study, the effect of P12A genotype on T2DM risk was modified by physical activity [23]. Combining all these results together, it may suggest an intrinsic reduction in the PPARgamma2 activity; however, it was shown that the A12 substitution in the PPARgamma2 gene associated with reduced lipoprotein lipase activity [24] which results in impaired clearance of LDL, VLDL resulting in elevated total plasma cholesterol, LDL, and VLDL levels. In contrast, other studies did not find impact of p.P12A of PPARgamma2 on lipid profile in diabetic and normoglycemic subjects [25]. We believe that ethnic differences, BMI, gender, physical activities, study design, and sample size all could be considered as reasons for discrepancies in association studies.
###end p 20
###begin p 21
###xml 257 263 257 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;2</italic>
###xml 354 362 <span type="species:ncbi:9606">patients</span>
In conclusion, this study is considered to be the first to focus on molecular type-2 diabetes on Palestinians which will help in draw a baseline for further diabetes research studies in Palestine. Our findings showed no significant impact of the p.P12A PPARgamma2 polymorphism on BMI, blood pressure and triglyceride. However, this variant in obese T2DM patients may influence cardiovascular risk through effects on lipid metabolism. The role of other polymorphisms particularly-if found-in a location near to the p.P12A is still to be defined in our population.
###end p 21
###begin title 22
Acknowledgments
###end title 22
###begin p 23
The authors would like to thank Dr. Umaya Khamash, Chief Field Health Program, and the UNRWA outpatient clinic TEAM at Amari Refugee camp in Ramallah for their support throughout the sample collections. The authors thank Dr. Adel Shalata for his critical review of the manuscript.
###end p 23
###begin article-title 24
Type-2 diabetes: a cocktail of genetic discovery
###end article-title 24
###begin article-title 25
Diabetes mellitus in an urban Palestinian population: prevalence and associated factors
###end article-title 25
###begin article-title 26
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR</italic>
###xml 4 9 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 10 18 6 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pro12Ala</sup>
###xml 36 41 <span type="species:ncbi:9606">human</span>
PPARgamma2Pro12Ala polymorphism and human health
###end article-title 26
###begin article-title 27
Peroxisome proliferators-activated receptor (PPAR) modulators and metabolic disorders
###end article-title 27
###begin article-title 28
###xml 47 52 47 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism
###end article-title 28
###begin article-title 29
###xml 27 36 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#947;</italic>
A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
###end article-title 29
###begin article-title 30
###xml 87 92 87 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 95 99 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR</italic>
###xml 100 105 96 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant Caucasians
###end article-title 30
###begin article-title 31
###xml 39 44 37 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
The Pro12 --> Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes
###end article-title 31
###begin article-title 32
###xml 29 38 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#947;</italic>
The Pro12Ala polymorphism in PPARgamma2 may confer resistance to type 2 diabetes
###end article-title 32
###begin article-title 33
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
Examining the relationships between the Pro12Ala variant in PPARG and type 2 diabetes-related traits in UK samples
###end article-title 33
###begin article-title 34
###xml 48 58 48 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR-gamma</italic>
Implication of the Pro12Ala polymorphism of the PPAR-gamma2 gene in type 2 diabetes and obesity in the French population
###end article-title 34
###begin article-title 35
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
Analysis of separate and combined effects of common variation in KCNJ11 and PPARG on risk of type 2 diabetes
###end article-title 35
###begin article-title 36
###xml 35 37 35 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR</italic>
###xml 66 71 66 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
Lack of association between the Pro12Ala polymorphism of the PPAR-gamma2 gene and type 2 diabetes mellitus in the Qatari consanguineous population
###end article-title 36
###begin article-title 37
###xml 46 49 46 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#966;</italic>
###xml 49 50 47 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 52 59 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#966;</italic>
###xml 59 60 55 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 153 161 <span type="species:ncbi:9606">patients</span>
The peroxisome proliterator activated receptorphi2 (PPARphi2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patients
###end article-title 37
###begin article-title 38
###xml 19 21 19 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sup>
###xml 80 85 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects
###end article-title 38
###begin article-title 39
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
###end article-title 39
###begin article-title 40
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRS1</italic>
###xml 6 12 6 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 14 23 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#947;</italic>
###xml 29 39 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF-1&#945;</italic>
IRS1, KCNJ11, PPARgamma2 and HNF-1alpha: do amino acid polymorphisms in these candidate genes support a shared aetiology between type 1 and type 2 diabetes?
###end article-title 40
###begin article-title 41
###xml 48 57 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#947;</italic>
Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population
###end article-title 41
###begin article-title 42
###xml 72 77 72 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 80 89 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#947;</italic>
###xml 200 208 <span type="species:ncbi:9606">patients</span>
Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male Caucasian type 2 diabetes patients
###end article-title 42
###begin article-title 43
###xml 77 82 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus
###end article-title 43
###begin article-title 44
###xml 108 113 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
Evidence for greater oxidative substrate flexibility in male carriers of the Pro 12 Ala polymorphism in PPARgamma2
###end article-title 44
###begin article-title 45
Glucose clamp technique: a method for quantifying insulin secretion and resistance
###end article-title 45
###begin article-title 46
###xml 8 13 8 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
SNPs in PPARG associate with type 2 diabetes and interact with physical activity
###end article-title 46
###begin article-title 47
###xml 78 83 78 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
The Proline 12 substitution in the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower lipoprotein lipase activity in vivo
###end article-title 47
###begin article-title 48
###xml 72 77 72 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes
###end article-title 48
###begin p 49
Anthropometrical and biochemical parameters of the study groups. Data are in means +/- SD. BMI =Body mass index; SBP=systolic blood pressure; DBP=diastolic blood pressure; TC: total cholesterol; TG: Triglyceride; FPG: fasting plasma glucose; NS: not significant; D: Diet; I: insulin; IO: Insulin and oral hypoglycemic agent; O: oral hypoglycemic agent.
###end p 49
###begin p 50
###xml 4 9 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 70 78 <span type="species:ncbi:9606">patients</span>
PPARgamma2 genotype frequencies in obese and nonobese Type 2 diabetic patients. The chi-square test was performed for association.
###end p 50
###begin p 51
###xml 70 75 70 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
Biochemical and anthropometrical parameters for subjects based on PPARgamma2 genotype. The chi-square test was performed for association.
###end p 51

